Michael G.

Michael G. has over 10 years of professional experience in the energy and healthcare industries. Michael began their career in 2009 as a Summer Intern at Renewable Silicon International and Eos Energy Storage (formerly Grid Storage Technologies). In 2011, they co-founded and served as President of Saturnis, where they were awarded over $60,000 in non-dilutive funding through multiple business plan competitions. In 2012, they co-founded and served as President of Aerosol Control Technologies (ACT), where they were awarded $20,000 in non-dilutive funding through multiple business plan competitions. In 2013, they joined Fraunhofer USA - Center for Sustainable Energy Systems as a TechBridge Fellow. Michael then joined Midori USA, Inc. as an Associate in Corporate Development and held various positions until 2016. In 2013, they joined Kaleido Biosciences as an Associate Director in Regulatory Affairs and held various positions until 2019. In 2019, they founded MJG Advising and served as Principal. In 2020, they founded Lingua Franca Therapeutics and served as Founder & CEO. Currently, they are the Head of Regulatory Affairs at Faeth Therapeutics.

Michael G. obtained their high school diploma from The Hun School of Princeton in 2008. Michael then attended Washington University in St. Louis, where they obtained a BS in Business Administration and Energy, Environmental, and Chemical Engineering, an M.Eng in the same field, and an MBA. In 2010 and 2011, they attended Imperial College London as an Occasional (Visiting) Student, studying Chemical Engineering & Metals and Energy Finance. In 2018, Michael G. obtained a Regulatory Affairs Certification (RAC) United States (US) from the Regulatory Affairs Professionals Society (RAPS). In 2019, they obtained a Regulatory Affairs Certification (RAC) European Union (EU) from the same institution.